FDA Recalls Thyroid Medication Due to Excessive Hormone Levels

The FDA has issued a nationwide recall for one lot of Vitruvias Therapeutics' Thyroid Tablets, USP 30 mg, after testing revealed they may contain superpotent levels of hormones. This poses significant health risks, particularly for vulnerable populations like older adults, pregnant women, and infants, as it could lead to hyperthyroidism. The recall aims to prevent adverse health effects from the potentially dangerous medication.